corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items published in 2010

There are 1617 items in the Healthy Skepticism Library that were published in 2010.

Page 4 of 17 pages ‹ First  < 2 3 4 5 6 >  Last ›

HSL18951
Hoey J
Should medical journals carry pharmaceutical advertising?: No
Can Fam Physician. 2010 Oct; 56:(10):979-81
http://www.cfp.ca/cgi/content/full/56/10/979

HSL18952
Dehaas D
Should medical journals carry pharmaceutical advertising?: Yes
Can Fam Physician 2010 Oct; 56:(10):978-80
http://www.cfp.ca/cgi/content/full/56/10/978

HSL19170
Big stick won’t work with industry sponsorship
MJA InSight 2010 Oct;
http://www.mjainsight.com.au/view?post=big-stick-won%25e2%2580% 2599t-work-with-industry-sponsorship&post_id=1112&cat=issue-15-11-october-2010

HSL19151
Mali SN, Dudhgaonkar S, Bachewar NP
Evaluation of rationality of promotional drug literature using World Health Organization guidelines
Indian J Pharmacol 2010 Oct; 42:(5):267-72
http://www.ijp-online.com/article.asp?issn=0253-7613;year=2010;volume=42;issue=5;spage=267;epage=272;aulast=Mali

HSL18729
Silverman E
Novartis Pays $422M For Off-Label Marketing
Pharmalot 2010 Sep 30
http://www.pharmalot.com/2010/09/novartis-pays-422m-for-off-label-marketing-charges/

HSL18765
Sharma DC
Egg on the academies' faces over eggplant
India Today 2010 Sep 30
http://indiatoday.intoday.in/site/Story/114526/centre-to-invite-all-groups-for-dialogue-on-kashmir.html?complete=1

HSL18833
Edwards J
Novartis Paid Kickbacks to Doc Lecturers Even If They Couldn't Speak English
BNet 2010 Sep 30
http://www.bnet.com/blog/drug-business/novartis-paid-kickbacks-to-doc-lecturers-even-if-they-couldn-8217t-speak-english/5942

HSL18958
Moynihan R.
Merging of marketing and medical science: female sexual dysfunction.
BMJ 2010 Sep 30; 341:c5050:
http://www.bmj.com/content/341/bmj.c5050.long

HSL19141
Angell M
FDA: This Agency Can Be Dangerous
The New York Review of Books 2010 Sep 30
http://www.nybooks.com/articles/archives/2010/sep/30/agency-can-be-dangerous/

HSL18730
Silverman E
The Shocking Truth About Free Lunches And Pens
Pharmalot 2010 Sep 29
http://www.pharmalot.com/2010/09/the-shocking-truth-about-free-lunches-and-pens/

HSL19200
Mckee S
Pfizer slapped with price-fixing fine in Indonesia
Pharma Times 2010 Sep 29
http://www.pharmatimes.com/Article/10-09-29/Pfizer_slapped_with_price-fixing_fine_in_Indonesia.aspx

HSL18956
Hunt P, Khosla R.
Are drug companies living up to their human rights responsibilities? The perspective of the former United nations special rapporteur (2002-2008).
PLoS Med 2010 Sep 28; 7:(9):
http://dx.plos.org/10.1371/journal.pmed.1000330

HSL18957
Gruskin S, Raad Z
Are drug companies living up to their human rights responsibilities? Moving toward assessment.
PLoS Med. 2010 Sep 28; 7:(9):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000310

HSL18973
Pfizer, Dexa fined for price fixing
The Jakarta Post 2010 Sep 28
http://www.thejakartapost.com/news/2010/09/28/pfizer-dexa-fined-price-fixing.html

HSL18985
Hendrick B
FDA: Popular Mouthwashes Make False Claims
WebMD 2010 Sep 28
http://www.webmd.com/oral-health/news/20100928/fda-popular-mouthwashes-make-false-claims

HSL19267
Drug Companies Should Be Held More Accountable for Their Human Rights Responsibilities
PLoS Med 2010 Sep 28;
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371% 2Fjournal.pmed.1000344

HSL18724
Silverman E
Pfizer Attacks Journal For Undisclosed Conflicts
Pharmalot 2010 Sep 27
http://www.pharmalot.com/2010/09/pfizer-attacks-journal-for-undisclosed-conflicts/

HSL18725
Elliott C, Fugh-Berman A, Barbour V
Concerns re: Incomplete 'Competing Interests' Disclosure
PLoS Med 2010 Sep 27;
http://www.plosmedicine.org/annotation/listThread.action?inReplyTo=info:doi/10.1371/annotation/9615f3f1-520f-43cd-a825-8afcab3c26d4&root=info:doi/10.1371/annotation/9615f3f1-520f-43cd-a825-8afcab3c26d4

HSL18731
Gordon S
Pediatricians Want to Restrict Ads for Tobacco, Booze, Viagra
Yahoo News 2010 Sep 27
http://news.yahoo.com/s/hsn/20100928/hl_hsn/pediatricianswanttorestrictadsfortobaccoboozeviagra

HSL18834
Edwards J
Blue Light Special: Viagra -- and Its Risks -- Now Available Without Rx in U.K. Supermarkets
BNet 2010 Sep 27
http://www.bnet.com/blog/drug-business/blue-light-special-viagra-8212-and-its-risks-8212-now-available-without-rx-in-uk-supermarkets/5875

HSL19662
Abshear D
MD$ on the Take: My Career-Ending Expose
HenryMakow.com 2010 Sep 27
http://www.henrymakow.com/i_was_a_corporate_whistle_blow.html

HSL18705
Silverman E
Avandia: Lessons Learned & Unanswered Questions
Pharmalot 2010 Sep 24
http://www.pharmalot.com/2010/09/avandia-lessons-learned-unanswered-questions/

HSL18706
Herper M
The End Of Drug Withdrawals?
Forbes Blog 2010 Sep 24
http://blogs.forbes.com/matthewherper/2010/09/24/the-end-of-drug-withdrawals/

HSL18770
Harrington C, Khanfar NM, Bond DR, Vila I
Utilising the medical literature for market research: Finding new approaches to marketing substance abuse treatment clinics
J Med Market 2010 Sep 24; 10:344-351
http://www.palgrave-journals.com/jmm/journal/v10/n4/abs/jmm201025a.html

HSL18704
Grogan K
European Parliament endorses drug monitoring rules
Pharma Times 2010 Sep 23
http://www.pharmatimes.com/Article/10-09-23/European_Parliament_endorses_drug_monitoring_rules.aspx

HSL18708
Breggin P
Making a Market in Antipsychotic Drugs: An Ironic Tragedy
The Huffington Post 2010 Sep 23
http://www.huffingtonpost.com/dr-peter-breggin/making-a-market-in-antips_b_720861.html

HSL18699
Kavilanz P
FDA: Motrin maker played us over recall
CNN Money 2010 Sep 22
http://money.cnn.com/2010/09/21/news/companies/Motrin_recall_fda_mcneil_exchange/index.htm

HSL18707
Cloud J
ADHD: A Global Epidemic or Just a Bunch of Fidgety Kids?
Time Healthland 2010 Sep 22
http://healthland.time.com/2010/09/22/adhd-a-global-epidemic-or-just-a-bunch-of-fidgety-kids/

HSL18718
Kuehn BM.
Inconsistent results, inaccurate claims plague direct-to-consumer gene tests.
JAMA 2010 Sep 22; 304:(12):1313-5
http://jama.ama-assn.org/cgi/content/full/304/12/1313

HSL18986
Stafford N
Proportion of spending on brand name drugs continues to rise in Germany
BMJ 2010 Sep 22; 341:
http://www.bmj.com/content/341/bmj.c5185.extract

HSL19268
Bastian H, Glasziou P, Chalmers I
Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up?
PLoS Med 2010 Sep 21;
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000326

HSL18696
Silverman E
Feds Intervene In Pfizer Suit Over Targeting Blacks
Pharmalot 2010 Sep 21
http://www.pharmalot.com/2010/09/feds-intervene-in-wyeth-suit-over-targeting-blacks/

HSL18698
Jack A
Pharmaceuticals: Perils for pill pushers
The Finanical Times 2010 Sep 21
http://www.ft.com/cms/s/5cc9d62e-c5b5-11df-ab48-00144feab49a,Authorised=false.html?_i_location=http://www.ft.com/cms/s/0/5cc9d62e-c5b5-11df-ab48-00144feab49a.html&_i_referer=

HSL18700
Wilson D
U.S. Joins Pfizer Suit Over Drug's Marketing
The New York Times 2010 Sep 21
http://www.nytimes.com/2010/09/22/business/22drug.html?_r=1

HSL18719
Greene JA
What's in a Name? Generics and the Persistence of the Pharmaceutical Brand in American Medicine.
J Hist Med Allied Sci 2010 Sept 21;
http://jhmas.oxfordjournals.org/content/early/2010/09/21/jhmas.jrq049.long

HSL18701
Silverman E
A Senate Investigator Looks Back: Thacker Speaks
Pharmalot 2010 Sep 20
http://www.pharmalot.com/2010/09/a-senate-investigator-looks-back-thacker-speaks/

HSL18703
Taylor L
Drugmakers protest new Greek prices
Pharma Times 2010 Sep 20
http://www.pharmatimes.com/Article/10-09-20/Drugmakers_protest_new_Greek_prices.aspx

HSL18987
Mudur G
Industry lobbying and trade pacts threaten India’s role as major generics supplier
BMJ 2010 Sep 20; 341:
http://www.bmj.com/content/341/bmj.c5135.extract

HSL18702
Newman M
Bitter pills for drug companies
BMJ 2010 Sep 17; 341:
http://www.bmj.com/content/341/bmj.c5095.extract

HSL18711
Annes JP, Giovanni MA, Murray MF.
Risks of presymptomatic direct-to-consumer genetic testing.
N Engl J Med 2010 Sep 16; 363:(12):1100-1
http://www.nejm.org/doi/full/10.1056/NEJMp1006029

HSL18694
Edwards J
$1,000 a Pop: How Forest Labs Bribed Doctors to Prescribe Antidepressants to Kids
BNet 2010 Sep 15
http://www.bnet.com/blog/drug-business/1000-a-pop-how-forest-labs-bribed-doctors-to-prescribe-antidepressants-to-kids/5753

HSL18713
Hamrell MR.
Raising Suspicions with the Food and Drug Administration: Detecting Misconduct.
Sci Eng Ethics 2010 Sep 15;
http://www.springerlink.com/content/xw4576h31m838186/

HSL18714
Sah S, Loewenstein G.
Effect of reminders of personal sacrifice and suggested rationalizations on residents' self-reported willingness to accept gifts: a randomized trial.
JAMA 2010 Sep 15; 304:(11):1204-11
http://jama.ama-assn.org/cgi/content/full/304/11/1204

HSL18837
Arnold M
Headliner: Grassley's Ghostwriter Exits Hill
Medical Marketing & Media 2010 Sep 15
http://www.mmm-online.com/headliner-grassleys-ghostwriter-exits-hill/article/180052/

HSL18905
Arnold M
Patient Marketing Report: Thinking Past the Pill
Medical Marketing & Media 2010 Sep 15
http://www.mmm-online.com/patient-marketing-report-thinking-past-the-pill/article/180045/

HSL19181
McQuillen W
Forest Unit Pleads Guilty to Marketing Thyroid Drug, Will Pay $313 Million
Bloomberg Businessweek 2010 Sep 15
http://www.bloomberg.com/news/2010-09-15/forest-unit-agrees-to-plead-guilty-pay-313-million-in-levothroid-cases.html

HSL18693
Wilson A, Robertson J, McElduff P, Jones A, Henry D
Does It Matter Who Writes Medical News Stories?
PLoS Med 2010 Sep 14;
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000323

HSL18697
Kowalczyk L
For physicians, another option on education
The Boston Globe 2010 Sep 14
http://www.boston.com/news/health/articles/2010/09/14/doctor_looks_to_cut_drug_industrys_sway_on_medicine/

HSL19252
Iskowitz M
New med-ed firm says no to industry funding
Medical Marketing & Media 2010 Sep 14
http://www.mmm-online.com/new-med-ed-firm-says-no-to-industry-funding/article/178875/

HSL18911
Chimonas S, Frosch Z, Rothman DJ
From Disclosure to Transparency: The Use of Company Payment Data
Arch Intern Med. 2010 Sep 13;
http://archinte.ama-assn.org/cgi/content/abstract/archinternmed.2010.341v1

HSL19276
O'Reilly KB
Drugmakers hold too much influence over doctors' decisions, public says
Americal Medical News 2010 Sep 13
http://www.ama-assn.org/amednews/2010/09/13/prsc0913.htm

HSL18695
Elliott C
The Secret Lives of Big Pharma's 'Thought Leaders'
The Chronicle of Higher Education 2010 Sep 12
http://chronicle.com/article/The-Secret-Lives-of-Big/124335/

HSL19182
Linder-Ganz R
Gehrig's patients demand Teva reveal Copaxone test results
Haaretz.com 2010 Sep 12
http://www.haaretz.com/print-edition/business/gehrig-s-patients-demand-teva-reveal-copaxone-test-results-1.313300

HSL18649
Feeley J
Allergan Directors Are Sued Over Marketing of Botox
Bloomberg.com 2010 Sep 8
http://www.bloomberg.com/news/2010-09-07/allergan-directors-are-sued-by-shareholders-over-marketing-of-botox-drug.html

HSL18669
Romualdez AG
Finger-pointing on ethics
Malaya 2010 Sep 8
http://www.malaya.com.ph/09082010/edromuald.html

HSL18671
Iskowitz M
Cephalon videos seek to bolster physician-patient dialogue
Medical Marketing & Media 2010 Sep 8
http://www.mmm-online.com/cephalon-videos-seek-to-bolster-physician-patient-dialogue/article/178482/

HSL18672
Staton T
Study details Wyeth ghostwriting on Prempro
Fierce Pharma 2010 Sep 8
http://www.fiercepharma.com/story/study-details-wyeth-ghostwriting-prempro/2010-09-08

HSL18650
Fugh-Berman AJ
The Haunting of Medical Journals: How Ghostwriting Sold 'HRT'
PLoS Med 2010 Sep 7; 7:(9):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000335

HSL18652
Silverman E
Non-Profits And Industry Money: Who Gets What
Pharmalot 2010 Sep 7
http://www.pharmalot.com/2010/09/non-profits-and-industry-money-who-gets-what/

HSL18653
Silverman E
'No-See' Docs Will Talk To Reps At CME Meetings
Pharmalot 2010 Sep 7
http://www.pharmalot.com/2010/09/no-see-docs-will-talk-to-reps-at-cme-meetings/

HSL18660
Goozner M
Drug Marketing - A Form of Malpractice
GoozNews 2010 Sep 7
http://www.gooznews.com/node/3426

HSL18670
Taylor L
Greece cuts prices of over 4,000 drugs by 20%
PharmaTimes 2010 Sep 7
http://www.pharmatimes.com/Article/10-09-07/Greece_cuts_prices_of_over_4_000_drugs_by_20.aspx

HSL18640
Shankar R
Panel anguished over unethical practices of pharma cos to evade price control
PharmaBiz.com 2010 Sep 6
http://news.indiamart.com/story/parliamentary-panel-unhappy-over-corrupt-practices-pharma-firms-89451.html

HSL18644
Cohen D
Rosiglitazone: what went wrong?
BMJ 2010 Sep 6; 341:
http://www.bmj.com/content/341/bmj.c4848.full

HSL18645
Godlee F
Are we at risk of being at risk?
BMJ 2010 Sep 6; 341:
http://www.bmj.com/content/341/bmj.c4766.full

HSL18651
Lehman R, Yudkin JS, Krumholz H, Hines HH
Licensing drugs for diabetes
BMJ 2010 Sep 6
http://www.bmj.com/content/341/bmj.c4805

HSL18657
Poses RM
At the End of Summer, Everybody, Well, Nearly Everybody (Allergan, CVS Caremark, Stryker, WellStar) Settles
Health Care Renewal Blog 2010 Sep 6
http://hcrenewal.blogspot.com/2010/09/at-end-of-summer-everybody-well-nearly.html

HSL18641
Relação entre médicos e IF: 'é possível fazer melhor!'
Jornal Médico de Família 2010 Sep 3
http://www.jmfamilia.com/index.php?option=com_content&task=view&id=1191&Itemid=27

HSL18675
Hopkins Tanne J
US blog questions drug company funding of continuing education for journalists
BMJ 2010 Sep 3; 341:
http://www.bmj.com/content/341/bmj.c4857.extract

HSL18680
Moynihan R
A health check for the business of medicine
ABC News 2010 Sep 3
http://www.abc.net.au/unleashed/stories/s3001738.htm

HSL18643
Silverman E
American Heart Association, Avandia & Ghostwriting
Pharmalot 2010 Sep 2
http://www.pharmalot.com/2010/09/american-heart-association-avandia-ghostwriting/

HSL18646
Larkin C
Allergan Will Pay Fine, Plead Guilty to Misdemeanor
Bloomberg.com 2010 Sep 2
http://www.bloomberg.com/news/2010-09-01/allergan-will-pay-600-million-plead-guilty-to-misdemeanor-in-botox-probe.html

HSL18655
Mack J
'Reasonable' $600 MILLION Fine for Misbranding BOTOX: I Guess Allergan's Suit Against FDA Paid Off!
Pharma Marketing Blog 2010 Sep 2
http://pharmamkting.blogspot.com/2010/09/reasonable-600-fine-for-misbranding.html

HSL18676
Iskowitz M
Meetings offer reps a shot at 'no-see' docs: survey
Medical Marketing & Media 2010 Sep 2
http://www.mmm-online.com/meetings-offer-reps-a-shot-at-no-see-docs-survey/article/178163/

HSL18677
Wilson D
Child’s Ordeal Shows Risks of Psychosis Drugs for Young
The New York Times 2010 Sep 2
http://www.nytimes.com/2010/09/02/business/02kids.html?_r=1

HSL18656
Mack J
Pharma Email Spam: Three Degrees of Separation for Merck, Pfizer, and Genentech
Pharma Marketing Blog 2010 Sep 1
http://pharmamkting.blogspot.com/2010/09/pharma-email-spam-three-degrees-of.html

HSL18666
Orofino J, Soto J, Casado MA, Oyagüez I.
Global Spending on Orphan Drugs in France, Germany, the UK, Italy and Spain during 2007.
Appl Health Econ Health Policy 2010 Sep 1; 8:(5):301-315
http://adisonline.com/healtheconomics/pages/articleviewer.aspx?year=2010&issue=08050&article=00002&type=abstract

HSL18679
Moynihan R
Sex drugs for women don't seem to be working
ABC News 2010 Sep 1
http://www.abc.net.au/unleashed/stories/s2998870.htm

HSL18681
Singer N
Maker of Botox Settles Inquiry
The New York Times 2010 Sep 1
http://www.nytimes.com/2010/09/02/business/02allergan.html?_r=1

HSL18682
O’Dowd A
Drug company denies allegations of bribery in Finnish justice ministry investigation
BMJ 2010 Sep 1; 341:
http://www.bmj.com/content/341/bmj.c4755.extract

HSL18683
Moynihan R
Sex, lies and pharmaceuticals
Radio National: Life Matters : ABC News 2010 Sep 1
http://www.abc.net.au/rn/lifematters/stories/2010/2997971.htm

HSL18607
Elliott C
Making a Killing
Mother Jones 2010 Sep
http://motherjones.com/toc/2010/09

HSL18608
Walley T.
Drugs, money and society (Part II).
Br J Clin Pharmacol 2010 Sep; 70:(3):342-5
http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2009.03569.x/abstract

HSL18659
Heavey S, Richwine L
FDA struggles to keep up with pitches old and new
Reuters Magazine 2010 Sep
http://static.reuters.com/resources/media/editorial/20100903/FDAMarketing.pdf

HSL18664
Lee AL
Who Are the Opinion Leaders? Physicians, Pharmacists, Patients, and Direct-to-Consumer Prescription Drug Advertising.
J Health Commun 2010 Sep; 15:(6):629-55
http://www.informaworld.com/smpp/content~db=all?content=10.1080/10810730.2010.499594

HSL18709
Lee AL.
The impact of direct-to-consumer prescription drug advertising research-a diffusion of policy analysis.
Health Commun 2010 Sep; 25:(6-7):619-21
http://www.ncbi.nlm.nih.gov/pubmed/20845169

HSL18710
Hartung DM, Evans D, Haxby DG, Kraemer DF, Andeen G, Fagnan LJ.
Effect of drug sample removal on prescribing in a family practice clinic.
Ann Fam Med 2010 Sep-Oct; 8:(5):402-9
http://www.annfammed.org/cgi/content/full/8/5/402

HSL18715
Nakayama DK.
In defense of industry-physician relationships.
Am Surg 2010 Sep; 76:(9):987-94
http://www.ncbi.nlm.nih.gov/pubmed/20836349

HSL18716
Hype on HPV: for Whose Benefit?
Monthly Index of Medical Specialities 2010 Sep

HSL18822
Faunce T, Townsend R, McEwan A.
The Vioxx pharmaceutical scandal: Peterson v Merke Sharpe & Dohme (Aust) Pty Ltd (2010) 184 FCR 1.
J Law Med 2010 Sep; 18:(1):38-49
http://www.ncbi.nlm.nih.gov/pubmed/20977160

HSL19266
Are Drug Companies Living Up to Their Human Rights Responsibilities? The Merck Perspective
PLoS Med. 2010 Sep;
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371% 2Fjournal.pmed.1000343

HSL18638
Niëns LM, Cameron A, Van de Poel E, Ewen M, Brouwer WBF, et al
Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World
PLoS Med 2010 Aug 31; 7:(8):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000333

HSL18647
Taylor L
US patients 'wary of drugmakers' influence over doctors
Pharma Times 2010 Aug 31
http://www.pharmatimes.com/Article/10-08-31/US_patients_“wary_of_drugmakers_influence_over_doctors”.aspx

HSL18665
Pinckney RG, Helminski AS, Kennedy AG, Maclean CD, Hurowitz L, Cote E.
The Effect of Medication Samples on Self-Reported Prescribing Practices: A Statewide, Cross-Sectional Survey.
J Gen Intern Med 2010 Aug 31;
http://www.springerlink.com/content/u34441r650521q05/

HSL18673
Online Health Advertisements Increasingly Trusted, Effective, 2010 About.com Health Study Finds
Fierce Pharma 2010 Aug 31
http://pharmalive.com/news/index.cfm?articleID=726157

HSL18674
AP
FDA issues warning to Baxter over drug promotion
Bloomberg Businessweek 2010 Aug 31
http://www.businessweek.com/ap/financialnews/D9HUH1FG0.htm

HSL18684
Comer B
Medscape.com tops with docs, says report
Medical Marketing & Media 2010 Aug 31
http://www.mmm-online.com/medscapecom-tops-with-docs-says-report/article/177971/

HSL18685
Taylor L
India mulls compulsory licensing for cancer drugs
Pharma Times 2010 Aug 31
http://www.pharmatimes.com/Article/10-08-31/India_mulls_compulsory_licensing_for_cancer_drugs.aspx

HSL18678
Moynihan R
The merging of marketing and medical science
ABC News 2010 Aug 30
http://www.abc.net.au/unleashed/stories/s2996546.htm

HSL18686
SOHM India Boosts Generic Pharmaceutical Marketing Program With up to 60 Field Staff and Sales Associates Covering India's Most Populated States
Market Watch 2010 Aug 30
http://www.marketwatch.com/story/sohm-india-boosts-generic-pharmaceutical-marketing-program-with-up-to-60-field-staff-and-sales-associates-covering-indias-most-populated-states-2010-08-30?reflink=MW_news_stmp

Page 4 of 17 pages ‹ First  < 2 3 4 5 6 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







As an advertising man, I can assure you that advertising which does not work does not continue to run. If experience did not show beyond doubt that the great majority of doctors are splendidly responsive to current [prescription drug] advertising, new techniques would be devised in short order. And if, indeed, candor, accuracy, scientific completeness, and a permanent ban on cartoons came to be essential for the successful promotion of [prescription] drugs, advertising would have no choice but to comply.
- Pierre R. Garai (advertising executive) 1963